Loading...

Japan Medical Dynamic Marketing, INC.

JMDMFPNK
Healthcare
Medical - Devices
$3.34
$0.00(0.00%)

Japan Medical Dynamic Marketing, INC. (JMDMF) Stock Overview

Explore Japan Medical Dynamic Marketing, INC.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap104.4M
P/E RatioN/A
EPS (TTM)$-0.12
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$3.95

JMDMF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Japan Medical Dynamic Marketing, INC. (JMDMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $3.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 104.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for JMDMFStats details for JMDMF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for JMDMFAnalyst Recommendations details for JMDMF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.

CEO

Toshiyuki Hironaka

Employees

511

Headquarters

12-2, Ichigayadaimachi, Tokyo

Founded

2022

Frequently Asked Questions

;